Literature DB >> 12069597

Nucleotide binding and nucleotide hydrolysis properties of the ABC transporter MRP6 (ABCC6).

Jie Cai1, Roni Daoud, Omar Alqawi, Elias Georges, Jerry Pelletier, Philippe Gros.   

Abstract

Mutations in the MRP gene family member MRP6 cause pseudoxanthoma elasticum (PXE) in humans, a disease affecting elasticity of connective tissues. The normal function of MRP6, including its physiological substrate(s), remains unknown. To address these issues, recombinant rat Mrp6 (rMrp6) was expressed in the methylotrophic yeast Pichia pastoris. The protein was expressed in the membrane fraction as a stable 170 kDa protein. Its nucleotide binding and hydrolysis properties were investigated using the photoactive ATP analogue 8-azido-[alpha-(32)P]ATP and compared to those of the drug efflux pump MRP1. rMrp6 can bind 8-azido-[alpha-(32)P]ATP in a Mg(2+)-dependent and EDTA-sensitive fashion. Co(2+), Mn(2+), and Ni(2+) can also support 8-azido-[alpha-(32)P]ATP binding by rMrp6 while Ca(2+), Cd(2+), and Zn(2+) cannot. Under hydrolysis conditions (at 37 degrees C), the phosphate analogue beryllium fluoride (BeF(x)()) can stimulate trapping of the 8-azido-[alpha-(32)P]adenosine nucleotide in rMrp6 (and in MRP1) in a divalent cation-dependent and temperature-sensitive fashion. This suggests active ATPase activity, followed by trapping and photo-cross-linking of the 8-azido-[alpha-(32)P]ADP to the protein. By contrast to MRP1, orthovanadate-stimulated nucleotide trapping in rMrp6 does not occur in the presence of Mg(2+) but can be detected with Ni(2+) ions, suggesting structural and/or functional differences between the two proteins. The rMrp6 protein can be specifically photolabeled by a fluorescent photoactive drug analogue, [(125)I]-IAARh123, with characteristics similar to those previously reported for MRP1 (1), and this photolabeling of rMrp6 can be modulated by several structurally unrelated compounds. The P. pastoris expression system has allowed demonstration of ATP binding and ATP hydrolysis by rMrp6. In addition to providing large amounts of active protein for detailed biochemical studies, this system should also prove useful to identify potential rMrp6 substrates in [(125)I]-IAARh123 photolabeling competition studies, as well as to study the molecular basis of PXE mutations, which are most often found in the NBD2 of MRP6.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12069597     DOI: 10.1021/bi012082p

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  17 in total

Review 1.  [Pseudoxanthoma elasticum].

Authors:  M S Ladewig; C Götting; C Szliska; P C Issa; H-M Helb; I Bedenicki; H P N Scholl; F G Holz
Journal:  Ophthalmologe       Date:  2006-06       Impact factor: 1.059

2.  Sterol transfer by ABCG5 and ABCG8: in vitro assay and reconstitution.

Authors:  Jin Wang; Fang Sun; Da-wei Zhang; Yongming Ma; Fang Xu; Jitendra D Belani; Jonathan C Cohen; Helen H Hobbs; Xiao-Song Xie
Journal:  J Biol Chem       Date:  2006-07-25       Impact factor: 5.157

Review 3.  Pseudoxanthoma Elasticum as a Paradigm of Heritable Ectopic Mineralization Disorders: Pathomechanisms and Treatment Development.

Authors:  Qiaoli Li; Koen van de Wetering; Jouni Uitto
Journal:  Am J Pathol       Date:  2018-11-07       Impact factor: 4.307

4.  Quantitative Trait Locus and Integrative Genomics Revealed Candidate Modifier Genes for Ectopic Mineralization in Mouse Models of Pseudoxanthoma Elasticum.

Authors:  Qiaoli Li; Vivek M Philip; Timothy M Stearns; Jason A Bubier; Benjamin L King; Benjamin E Low; Michael V Wiles; Amir Hossein Saeidian; Beth A Sundberg; Jouni Uitto; John P Sundberg
Journal:  J Invest Dermatol       Date:  2019-06-15       Impact factor: 8.551

5.  Stabilization of Nucleotide Binding Domain Dimers Rescues ABCC6 Mutants Associated with Pseudoxanthoma Elasticum.

Authors:  Yanchao Ran; Patrick H Thibodeau
Journal:  J Biol Chem       Date:  2016-12-19       Impact factor: 5.157

Review 6.  Pseudoxanthoma elasticum: a clinical, pathophysiological and genetic update including 11 novel ABCC6 mutations.

Authors:  N Chassaing; L Martin; P Calvas; M Le Bert; A Hovnanian
Journal:  J Med Genet       Date:  2005-05-13       Impact factor: 6.318

7.  Cystic fibrosis transmembrane conductance regulator: the NBF1+R (nucleotide-binding fold 1 and regulatory domain) segment acting alone catalyses a Co2+/Mn2+/Mg2+-ATPase activity markedly inhibited by both Cd2+ and the transition-state analogue orthovanadate.

Authors:  Jean Philippe Annereau; Young Hee Ko; Peter L Pedersen
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

8.  Zinc is both an intracellular and extracellular regulator of KATP channel function.

Authors:  Anne-Lise Prost; Alain Bloc; Nicolas Hussy; Renaud Derand; Michel Vivaudou
Journal:  J Physiol       Date:  2004-06-24       Impact factor: 5.182

9.  Modulation of the ATPase and transport activities of broad-acting multidrug resistance factor ABCC10 (MRP7).

Authors:  Ekaterina V Malofeeva; Natalya Domanitskaya; Mariya Gudima; Elizabeth A Hopper-Borge
Journal:  Cancer Res       Date:  2012-10-19       Impact factor: 12.701

10.  Mg2+-dependent interactions of ATP with the cystathionine-β-synthase (CBS) domains of a magnesium transporter.

Authors:  Yusuke Hirata; Yosuke Funato; Yu Takano; Hiroaki Miki
Journal:  J Biol Chem       Date:  2014-04-06       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.